Found: 27
Select item for more details and to access through your institution.
ASCPT News.
- Published in:
- 2022
- Publication type:
- Proceeding
How a Pandemic Simultaneously Strengthened Existing Fundamentals and Drove New Innovations in Clinical Pharmacology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1141, doi. 10.1002/cpt.2758
- By:
- Publication type:
- Article
Off‐Label, but on‐Evidence? A Review of the Level of Evidence for Pediatric Pharmacotherapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1243, doi. 10.1002/cpt.2736
- By:
- Publication type:
- Article
The Broader Context of Liquid Biopsy in Absorption, Distribution, Metabolism, and Elimination.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1154, doi. 10.1002/cpt.2734
- By:
- Publication type:
- Article
Response to Rowland et al. and Achour et al.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1155, doi. 10.1002/cpt.2733
- By:
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1145, doi. 10.1002/cpt.2756
- Publication type:
- Article
Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines: A Systematic Review.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1318, doi. 10.1002/cpt.2754
- By:
- Publication type:
- Article
Is Liquid Biopsy Only Restricted to Diagnostics or Can it Go Beyond the Confines of Genotyping and Phenotyping for Quantitative Pharmacology?
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1152, doi. 10.1002/cpt.2732
- By:
- Publication type:
- Article
Integration of Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy into Model‐Informed Dose Selection in Oncology First‐in‐Human Study: A Case of Roblitinib (FGF401).
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1329, doi. 10.1002/cpt.2752
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1139, doi. 10.1002/cpt.2751
- Publication type:
- Article
Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta‐Analysis of Prospective, Controlled Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1303, doi. 10.1002/cpt.2748
- By:
- Publication type:
- Article
Population PK and PD Analysis of Domagrozumab in Pediatric Patients with Duchenne Muscular Dystrophy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1291, doi. 10.1002/cpt.2747
- By:
- Publication type:
- Article
Changes in Sertraline Plasma Concentrations Across Pregnancy and Postpartum.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1280, doi. 10.1002/cpt.2746
- By:
- Publication type:
- Article
Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non‐alcoholic Steatohepatitis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1271, doi. 10.1002/cpt.2745
- By:
- Publication type:
- Article
Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [<sup>11</sup>C]Telmisartan.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1264, doi. 10.1002/cpt.2744
- By:
- Publication type:
- Article
Physiologically‐Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug–Drug Interactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1254, doi. 10.1002/cpt.2738
- By:
- Publication type:
- Article
DNA‐Thioguanine Nucleotides as a Marker for Thiopurine Induced Late Leukopenia after Dose Optimizing by NUDT15 C415T in Chinese Patients with IBD.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1236, doi. 10.1002/cpt.2730
- By:
- Publication type:
- Article
Sotrovimab Lowers the Risk of COVID‐19 Related Hospitalization or Death in a Large Population Cohort in the United Arab Emirates.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1214, doi. 10.1002/cpt.2700
- By:
- Publication type:
- Article
Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV‐2.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1224, doi. 10.1002/cpt.2728
- By:
- Publication type:
- Article
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV‐2 Infection.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1207, doi. 10.1002/cpt.2706
- By:
- Publication type:
- Article
Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1201, doi. 10.1002/cpt.2683
- By:
- Publication type:
- Article
Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1191, doi. 10.1002/cpt.2646
- By:
- Publication type:
- Article
Managing Potential Drug Interactions of Nirmatrelvir/Ritonavir in COVID‐19 Patients: A Perspective from an Israeli Cross‐Sector Collaboration.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1156, doi. 10.1002/cpt.2610
- By:
- Publication type:
- Article
Estimands and Complex Innovative Designs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1183, doi. 10.1002/cpt.2575
- By:
- Publication type:
- Article
The Current Landscape and Emerging Applications for Real‐World Data in Diagnostics and Clinical Decision Support and its Impact on Regulatory Decision Making.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1172, doi. 10.1002/cpt.2565
- By:
- Publication type:
- Article
PharmVar GeneFocus: CYP3A5.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1159, doi. 10.1002/cpt.2563
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1131, doi. 10.1002/cpt.2303
- Publication type:
- Article